- Fujifilm reported an operating income of 75.29 billion yen for the first quarter, surpassing the estimate of 69.55 billion yen.
- Net income was slightly below expectations, at 53.77 billion yen compared to the estimated 54.75 billion yen.
- Net sales came in at 749.48 billion yen, under the estimated 758.52 billion yen.
- For the 2026 year forecast, Fujifilm projects an operating income of 331.00 billion yen, slightly above the estimate of 330.2 billion yen.
- Net income forecast for 2026 is 262.00 billion yen, exceeding the estimation of 257.91 billion yen.
- Projected net sales for 2026 are 3.28 trillion yen, marginally above the estimated 3.27 trillion yen.
- The company maintains its dividend forecast at 70.00 yen, matching market expectations.
- Analysts’ recommendations include 12 buy ratings, 5 hold ratings, and no sell ratings for Fujifilm.
FUJIFILM Holdings on Smartkarma
Analyst coverage of FUJIFILM Holdings on Smartkarma highlights the success of its Bio CDMO business. Shifara Samsudeen, FCMA, CGMA, in a report titled “Fujifilm: Bio CDMO – A Success in the Making,” expresses a bullish sentiment towards the company’s recent achievements. Fujifilm secured a $3 billion manufacturing deal with Regeneron Pharma, demonstrating significant growth and success in its Bio CDMO business. The strategic investments and acquisitions made by Fujifilm, particularly through FUJIFILM Diosynth Biotechnologies, have driven this success, with a focus on expanding capabilities. The Bio CDMO business is projected to generate revenues of ¥200 billion by FY03/2025 and aims to reach ¥500 billion by FY03/2028.
A look at FUJIFILM Holdings Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
According to Smartkarma Smart Scores, FUJIFILM Holdings Corporation holds a positive long-term outlook. The company received a high score of 4 in Value, indicating strong value potential. In addition, FUJIFILM received scores of 3 in Dividend, Growth, and Resilience, highlighting its stable performance across these key factors. Furthermore, the company scored a 4 in Momentum, suggesting a positive trend in its market performance.
FUJIFILM Holdings is known for developing, selling, and servicing Imaging, Information, and Document Solutions. Its wide range of products includes color films, digital cameras, photofinishing products, medical equipment, graphic art materials, FPD materials, and optical devices. The company also provides services for office copy machines, printers, and related equipment, showcasing its diversification within the industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
